Prenatal Administration of Betamethasone and Neonatal Respiratory Distress Syndrome in Multifetal Pregnancies: A Randomized Controlled Trial.

CONCLUSION: Betamethasone therapy during 28-32 weeks of gestation in multifetal pregnancies was associated with better neonatal outcomes through significant reductions in NRDS incidence and requiring ventilator treatment. However, betamethasone administration did not reduce the chance of NRDS in premature infants. PMID: 33070770 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/33070770?dopt=Abstract

Source: Current Clinical Pharmacology - October 21, 2020 Category: Drugs & Pharmacology Authors: Abbasalizadeh F, Pouya K, Zakeri R, Asgari-Arbat R, Abbasalizadeh S, Parnianfard N Tags: Curr Clin Pharmacol Source Type: research